Aap Implantate AG Completes 5.7% Capital Increase

aap Implantate AG successfully executed a 5.7% capital increase from authorized capital, setting the placement price at EUR 1.34, without subscription rights. This move, announced on December 4, 2025, resulted in cash proceeds of EUR 1,056,121.00 for the company. The cash inflow is earmarked to bolster investments aimed at gaining approval for its innovative antibacterial implant technology. The capital increase saw strong interest and was oversubscribed.

aap Implantate AG, a Berlin-based medical technology company, specializes in traumatology products. Its portfolio includes the LOQTEQ® anatomical plate system and a variety of screw plates. The company is also developing advanced technologies such as antibacterial silver coatings and magnesium-based implants. aap Implantate AG markets its products directly in Germany and through distributors in 31 countries globally.